G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide
G2E3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all G2E3 products
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IWQRGKEEEG VYGFLIEDIR KEVNRASKLK CCVCKKNGAS IGCVAPRCKR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1333 antibody,
Alternative Names: KIAA1333 control peptide, KIAA1333 antibody Blocking Peptide, Anti-KIAA1333 Blocking Peptide, Kiaa1333 Blocking Peptide, FLJ20333 Blocking Peptide, G2E3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Background
- KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
- Molecular Weight
- 80 kDa
-
You are here:
